4D Molecular Therapeutics (FDMT) Change in Receivables (2020 - 2022)
4D Molecular Therapeutics' (FDMT) quarterly Change in Receivables came in at -$47000.0 in Q1 2022, up 90.98% year-on-year from -$24610.1 in Q1 2021, and up 93.68% on a QoQ basis from -$744000.0 in Q4 2021.
4D Molecular Therapeutics (FDMT) Change in Receivables (2020 - 2022) Analysis & Trends
4D Molecular Therapeutics (FDMT) has 3 years of Change in Receivables data on file, last reported at -$47000.0 in Q1 2022.
- On a quarterly basis, Change in Receivables rose 90.98% year-over-year to -$47000.0 in Q1 2022; TTM through Dec 2022 was -$47000.0, a 96.73% increase from a year earlier, with the FY2022 full-year figure at -$47000.0, up 96.73% from the prior year.
- Change in Receivables for Q1 2022 stood at -$47000.0, up from -$744000.0 in the prior quarter.
- Over the last five years, Change in Receivables for FDMT reached as high as $590000.0 in Q4 2020 and fell as low as -$744000.0 in Q4 2021.
- Historically, Change in Receivables has averaged -$108666.7 across 3 years, with a median of -$99000.0 in 2020.
- On a YoY basis, Change in Receivables climbed as much as 267.55% in 2021 and fell as far as 426.26% in 2021.
- Year by year, Change in Receivables stood at $590000.0 in 2020, then plunged by 226.1% to -$744000.0 in 2021, then jumped by 93.68% to -$47000.0 in 2022.
- Per Business Quant data, the three most recent Change in Receivables figures were -$47000.0 in Q1 2022, -$744000.0 in Q4 2021, and -$427000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | 4D Molecular Therapeutics | 691.54 Mn | 300.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -47,000.00 |
| Mar 31, 2022 | -47,000.00 |
| Dec 31, 2021 | -744,000.00 |
| Dec 31, 2021 | -744,000.00 |
| Sep 30, 2021 | -427,000.00 |
| Sep 30, 2021 | -427,000.00 |
| Jun 30, 2021 | 253,000.00 |
| Jun 30, 2021 | 253,000.00 |
| Mar 31, 2021 | -521,000.00 |
| Mar 31, 2021 | -521,000.00 |
| Dec 31, 2020 | 590,000.00 |
| Dec 31, 2020 | 590,000.00 |
| Sep 30, 2020 | 168,000.00 |
| Sep 30, 2020 | 168,000.00 |
| Jun 30, 2020 | -151,000.00 |
| Jun 30, 2020 | -151,000.00 |
| Mar 31, 2020 | -99,000.00 |
| Mar 31, 2020 | -99,000.00 |